Safety, Tolerability and Efficacy of YH14618 in Patients With Degenerative Disc Disease
Status:
Completed
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to assess the safety and tolerability of YH14618 during 24
weeks of follow-up period after single administration in patients with degenerative disc
disease.